Similar articles

• Inhibition with NCO-700, a protease inhibitor, of degradation of cardiac myofibrillar proteins during ischemia in dogs.

  Sashida H, Abiko Y. Sashida H, et al. Biochem Pharmacol. 1985 Nov 1;34(21):3875-80. doi: 10.1016/0006-2952(85)90437-x. Biochem Pharmacol. 1985. PMID: 4062961
• Platelet aggregation induced by platelet-activating factor is suppressed by cystine protease inhibitor.

  Takano H, Kawaguchi H, Iizuka K, Yasuda H. Takano H, et al. Biochem Med Metab Biol. 1991 Feb;45(1):41-7. doi: 10.1016/0885-4505(91)90006-7. Biochem Med Metab Biol. 1991. PMID: 2015107
• The role of calcium activated neutral protease on myocardial cell injury in hypoxia.

  Iizuka K, Kawaguchi H, Yasuda H, Kitabatake A. Iizuka K, et al. Jpn Heart J. 1992 Sep;33(5):707-15. doi: 10.1536/ihj.33.707. Jpn Heart J. 1992. PMID: 1289600
• Role of calcium-activated neutral protease (calpain) with diet and exercise.

  Belcastro AN, Albisser TA, Littlejohn B. Belcastro AN, et al. Can J Appl Physiol. 1996 Oct;21(5):328-46. doi: 10.1139/h96-029. Can J Appl Physiol. 1996. PMID: 8905185 Review.
• [Protease inhibition in the reperfused ischemic myocardium--myocardial protection by aprotinin].

  Sunamori M. Sunamori M. Kyobu Geka. 1988 May;41(5):364-9. Kyobu Geka. 1988. PMID: 2457728 Review. Japanese. No abstract available.